Improvements in physical wellbeing over the first two years on antiretroviral therapy in western Kenya - Wikidata - awgldk - TriplyDB

Improvements in physical wellbeing over the first two years on antiretroviral therapy in western Kenya

Improvements in physical wellbeing over the first two years on antiretroviral therapy in western Kenya

http://www.wikidata.org/entity/Q33795359

about

The Impact of Company-Level ART Provision to a Mining Workforce in South Africa: A Cost-Benefit Analysis Economic returns to investment in AIDS treatment in low and middle income countries.Economic outcomes of patients receiving antiretroviral therapy for HIV/AIDS in South Africa are sustained through three years on treatment.Health and functional status among older people with HIV/AIDS in Uganda Assessment of the face validity of two pain scales in Kenya: a validation study using cognitive interviewing.A systematic review of treatment fatigue among HIV-infected patients prescribed antiretroviral therapy.An obese body mass increases the adverse effects of HIV/AIDS on balance and gait.Prevalence and correlates of pain and pain treatment in a western Kenya referral hospital.Palliative care and support for persons with HIV/AIDS in 7 African countries: implementation experience and future priorities.Antiretroviral therapy adherence in a sample of men with low socioeconomic status: The role of task-specific treatment self-efficacy.

P2860

Q28608172-49512B49-D384-470E-B9FF-C1AA20CCFD92 Q31036894-07825A69-576D-42F2-9EE3-AF025B538D04 Q33697770-CF83B1AE-EFBB-40FA-92D5-15E08E849668 Q34081968-43DAF7EB-AACA-4A2E-BB6C-0A5DF1DB099B Q34237452-C0C2545E-7A18-4A3E-840F-71A2F8E5299B Q35044399-F70A97C0-F873-44CF-9FB2-AFC872715AB4 Q35086013-6C055E93-ABAE-4C57-B036-D7293FA60283 Q35894809-D261DCD6-B042-4550-B181-5AD9A9F50777 Q38420563-454FCD1D-AB04-4B40-B2FE-DDD34D2AADE0 Q41640831-CB245AE1-2C78-453C-9B0C-70388816C597

P2860

Improvements in physical wellbeing over the first two years on antiretroviral therapy in western Kenya

http://www.wikidata.org/entity/Q33795359

description

2010 nî lūn-bûn

@nan

2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Improvements in physical wellb ...... viral therapy in western Kenya

@ast

Improvements in physical wellb ...... viral therapy in western Kenya

@en

type

label

Improvements in physical wellb ...... viral therapy in western Kenya

@ast

Improvements in physical wellb ...... viral therapy in western Kenya

@en

prefLabel

Improvements in physical wellb ...... viral therapy in western Kenya

@ast

Improvements in physical wellb ...... viral therapy in western Kenya

@en

P1433

Q33795359-0A6E46A7-CFA6-4293-9AC6-D806977FF12D

P1476

Q33795359-9CC3A0DF-7CCA-4B51-BAC2-B6AAF2D4F433

P2093

Q33795359-1612F4A3-2122-452A-A531-8E4E6036AF04

Q33795359-192E6535-7B03-4E4D-B3E4-5F0F701CA536

Q33795359-2862204B-B512-4B2A-9A45-9434785EE171

Q33795359-4B165907-9082-4CDC-9317-03B5DA8784D5

Q33795359-91B2B8C5-7492-4463-B39C-2DEDAFFEF311

Q33795359-CC61C47D-78F3-4DED-B52D-100C19183848

P2860

Q33795359-03225026-C205-4E71-A963-20ED0262FC52

Q33795359-159749E6-CA39-4A0C-9320-1FF043C4CAB2

Q33795359-2ED679E1-28ED-4F46-8A30-3AC94CE59B1C

Q33795359-39A426E8-0F0A-4881-B4BA-1B913D3D513A

Q33795359-3AFFAAD2-7639-4BEB-8F98-5C1CB643DC07

Q33795359-439BD140-AFD9-453E-B9B8-90F325DEA880

Q33795359-4F0FA262-AF4B-4D90-B0D4-004861C1FFC3

Q33795359-74E3152C-ACF0-4C55-B335-C2909B4BCD1C

Q33795359-828A4778-80E5-4D95-8D1F-0520104B8B35

Q33795359-9AE67A49-59ED-4919-8380-1127F73B6EF9

P304

Q33795359-7D99083A-EAEF-4065-95DD-A916C9D0F11C

P31

Q33795359-4A78CC71-4FEC-4E5E-9785-2860CF572887

P356

Q33795359-595DFB58-6105-4131-B9CE-EE516F97532A

P433

Q33795359-89869222-2CCD-4BEB-BC46-2068423D6842

P478

Q33795359-2EF43FB1-6898-4425-AC1A-B300D04556D0

P50

Q33795359-08D0C670-A683-4C30-BC30-4BED2BC60CC4

Q33795359-21FAF8D6-7990-4DC1-AD17-9714651ACA04

Q33795359-43780184-56D7-4FBB-A5F1-55019C27B487

Q33795359-470FD44A-A76F-40FB-97BD-FC4A2BD00F66

P577

Q33795359-B4D980FD-FAB1-4AB9-8B52-819415ABD7C0

P5875

Q33795359-C7C19CC9-8311-47AD-BC85-DA68883F269E

P698

Q33795359-DFC44D77-FD76-4902-A90D-114D9BE3E7DC

P921

Q33795359-635DF510-06B4-482A-8C58-DC9161C3B426

Q33795359-E744B0B0-6A7E-4A6F-BDF7-18EFEEE3A2E5

P932

Q33795359-847F2B99-4273-4CEF-9E24-F00F3D051569

P356

09540120903038366

P1433

P1476

Improvements in physical wellb ...... viral therapy in western Kenya

@en

P2093

Carolyne Sigei

http://www.w3.org/2001/XMLSchema#string

Douglas Shaffer

http://www.w3.org/2001/XMLSchema#string

Fred Sawe

http://www.w3.org/2001/XMLSchema#string

Kelly McCoy

http://www.w3.org/2001/XMLSchema#string

Margaret Bii

http://www.w3.org/2001/XMLSchema#string

Monique Wasunna

http://www.w3.org/2001/XMLSchema#string

P2860

Prolongation and quality of life for HIV-infected adults treated with highly active antiretroviral therapy (HAART): a balancing act

Economic and quality of life outcomes of antiretroviral therapy for HIV/AIDS in developing countries: a systematic literature review

Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review

Trends and predictors of quality of life among HIV-infected adults taking highly active antiretroviral therapy in rural Uganda.

Quality of life in asymptomatic- and symptomatic HIV infected patients in a trial of ritonavir/saquinavir therapy. The Prometheus Study Group.

High prevalence of HIV infection among rural tea plantation residents in Kericho, Kenya.

Quality of life and depression among HIV-infected patients receiving efavirenz- or protease inhibitor-based therapy in Senegal.

Health-related quality of life in HIV-infected naive patients treated with nelfinavir or nevirapine associated with ZDV/3TC (the COMBINE-QoL substudy).

Evaluating health-related wellbeing outcomes among outpatient adults with human immunodeficiency virus infection in the HAART era.

Differences in normal activities, job performance and symptom prevalence between patients not yet on antiretroviral therapy and patients initiating therapy in South Africa.

P304

137-145

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/09540120903038366

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

22

http://www.w3.org/2001/XMLSchema#string

P50

Jonathon L Simon

Bruce A. Larson

P577

2010-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

43135499

http://www.w3.org/2001/XMLSchema#string

P698

20390492

http://www.w3.org/2001/XMLSchema#string

P921

antiretroviral drug

P932

2856113

http://www.w3.org/2001/XMLSchema#string